Tag: iavi

World AIDS Vaccine Day: Together, we can achieve a world without AIDS

Written by on May 19, 2014 in Press Releases with 1 Comment

May 18, 2014 Do you remember the world before HIV/AIDS? Where will you be when the shadow of this disease is finally gone? We have seen major advances in preventing and treating HIV/AIDS – but millions of people are still becoming infected and dying. In East and Southern Africa, 10.5 million children have lost one […]

Continue Reading

Theraclone Sciences Announces Identification of New Vulnerable Site on HIV Using Antibodies

Theraclone Sciences Announces Identification of New Vulnerable Site on HIV Using Antibodies

Written by on April 25, 2014 in Press Releases with 0 Comments

Study Published in Immunity in Collaboration with The Scripps Research Institute and IAVI April 25, 2014 Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced the publication of data in the May issue of Immunity regarding antibodies with significant potency and breadth against human immunodeficiency virus (HIV). The study, titled “Broadly neutralizing HIV antibodies define a […]

Continue Reading

Download: Innovative partnerships in HIV vaccine research & development

Download: Innovative partnerships in HIV vaccine research & development

Written by on August 27, 2013 in Partnering and Corporate strategy, R&D with 0 Comments

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Hansi J. Dean, Ph.D., Director of New Alliances at […]

Continue Reading

Exciting HIV vaccine research with bNAbs overcomes key obstacle

Exciting HIV vaccine research with bNAbs overcomes key obstacle

Written by on April 3, 2013 in Featured on App, Prophylactic Vaccines, R&D with 0 Comments

A new technique for vaccine design may help overcome an important obstacle in developing a vaccine against HIV. Researchers at The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) were able to use the novel technique to, for the first time, stimulate immune cells that can produce broadly neutralizing antibodies that can […]

Continue Reading

Optimising the design, oversight, and execution of globalised studies

Optimising the design, oversight, and execution of globalised studies

Written by on November 16, 2012 in R&D with 0 Comments

Patricia Fast from IAVI joined us at the World Vaccine Congress Washington 2012 to discuss the potential for an HIV vaccine. 30 years after the initial cases of AIDS, HIV continues to devastate. In 2009, there were 33.3 million people living with HIV worldwide. With 7100 new HIV infections daily adding up to 2.6 million […]

Continue Reading

Live event feed: Dr Hanzi Dean

Live event feed: Dr Hanzi Dean

Written by on October 17, 2012 in R&D with 0 Comments

Dr. Dean is Director of New Alliances at the International AIDS Vaccine Initiative (IAVI), where she leads technology identification efforts geared toward addressing unmet needs in a portfolio of international collaborative HIV vaccine research and development projects. Prior to joining IAVI, Dr. Dean was Director of Program Management with PowderJect Vaccines, Inc., managing a portfolio […]

Continue Reading

Exciting new advances in HIV

Exciting new advances in HIV

Written by on August 16, 2012 in Featured on App, Prophylactic Vaccines, R&D with 0 Comments

HIV is global issue complicated by the poverty of the countries most affected. In 1981, HIV was discovered as the causal agent behind AIDS, and 30 years later HIV continues to be a serious problem with approximately 33.3 million people living with the disease in 2009. Margaret McGlynn, President & Chief Executive Officer, IAVI joined […]

Continue Reading

HIV #vaccine scientific progress and challenges by IAVI

HIV #vaccine scientific progress and challenges by IAVI

Written by on March 27, 2012 in Featured Videos with 1 Comment

Hansi Dean, Director New Alliances at International AIDS Vaccine Initiative (IAVI) delivered a presentation on HIV vaccine scientific progress and challenges at the World Vaccine Congress Lyon 2011 Key topics raised on her presentation included: The HIV prevention landscape Broadly neutralizing human monoclonal antibodies IAVI-corporate partnerships in HIV vaccine design Watch the video now or […]

Continue Reading

Top
Geolocation